HEPATOLOGÍA EXPERIMENTAL Y VECTORIZACIÓN DE FÁRMACOS
HEVEFARM
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (7)
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2019
-
Exploring target genes involved in the effect of quercetin on the response to oxidative stress in caenorhabditis elegans
Antioxidants, Vol. 8, Núm. 12
-
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Hepatology, Vol. 70, Núm. 2, pp. 547-562
2018
-
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1468-1477
2013
-
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2212-2219
2011
-
Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids
Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 18, Núm. 5, pp. 740-750
-
Nitric oxide mimics transcriptional and post-translational regulation during α-Tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes
Journal of Hepatology, Vol. 55, Núm. 1, pp. 133-144